Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of MRI in primary brain tumor evaluation.
Leung D, Han X, Mikkelsen T, Nabors LB. Leung D, et al. Among authors: nabors lb. J Natl Compr Canc Netw. 2014 Nov;12(11):1561-8. doi: 10.6004/jnccn.2014.0156. J Natl Compr Canc Netw. 2014. PMID: 25361803 Review.
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.
Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Ribas IG, Desideri S, Ye X; Adult Brain Tumor Consortium. Blakeley JO, et al. Among authors: nabors lb. Clin Cancer Res. 2019 Jan 1;25(1):73-79. doi: 10.1158/1078-0432.CCR-18-0110. Epub 2018 Aug 21. Clin Cancer Res. 2019. PMID: 30131387 Free PMC article. Clinical Trial.
Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study.
Fathallah-Shaykh HM, DeAtkine A, Coffee E, Khayat E, Bag AK, Han X, Warren PP, Bredel M, Fiveash J, Markert J, Bouaynaya N, Nabors LB. Fathallah-Shaykh HM, et al. Among authors: nabors lb. PLoS Med. 2019 May 28;16(5):e1002810. doi: 10.1371/journal.pmed.1002810. eCollection 2019 May. PLoS Med. 2019. PMID: 31136584 Free PMC article.
Implementation and utilization of the molecular tumor board to guide precision medicine.
Harada S, Arend R, Dai Q, Levesque JA, Winokur TS, Guo R, Heslin MJ, Nabell L, Nabors LB, Limdi NA, Roth KA, Partridge EE, Siegal GP, Yang ES. Harada S, et al. Among authors: nabors lb. Oncotarget. 2017 Jun 14;8(34):57845-57854. doi: 10.18632/oncotarget.18471. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915716 Free PMC article. Review.
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.
Horbinski C, Ligon KL, Brastianos P, Huse JT, Venere M, Chang S, Buckner J, Cloughesy T, Jenkins RB, Giannini C, Stupp R, Nabors LB, Wen PY, Aldape KJ, Lukas RV, Galanis E, Eberhart CG, Brat DJ, Sarkaria JN. Horbinski C, et al. Among authors: nabors lb. Neuro Oncol. 2019 Dec 17;21(12):1498-1508. doi: 10.1093/neuonc/noz119. Neuro Oncol. 2019. PMID: 31276167 Free PMC article. Review.
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
Lee EQ, Weller M, Sul J, Bagley SJ, Sahebjam S, van den Bent M, Ahluwalia M, Campian JL, Galanis E, Gilbert MR, Holdhoff M, Lesser GJ, Lieberman FS, Mehta MP, Penas-Prado M, Schreck KC, Strowd RE, Vogelbaum MA, Walbert T, Chang SM, Nabors LB, Grossman S, Reardon DA, Wen PY. Lee EQ, et al. Among authors: nabors lb. Neuro Oncol. 2020 May 15;22(5):601-612. doi: 10.1093/neuonc/noaa015. Neuro Oncol. 2020. PMID: 31974566 Free PMC article.
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery.
Grossman SA, Romo CG, Rudek MA, Supko J, Fisher J, Nabors LB, Wen PY, Peereboom DM, Ellingson BM, Elmquist W, Barker FG, Kamson D, Sarkaria JN, Timmer W, Bindra RS, Ye X. Grossman SA, et al. Among authors: nabors lb. Neuro Oncol. 2020 Oct 14;22(10):1422-1424. doi: 10.1093/neuonc/noaa142. Neuro Oncol. 2020. PMID: 32506123 Free PMC article. No abstract available.
171 results